{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:03:15Z","timestamp":1795042995168,"version":"4.10.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-130253"],"award-info":[{"award-number":["HL-130253"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-157281"],"award-info":[{"award-number":["HL-157281"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F30HL163915"],"award-info":[{"award-number":["F30HL163915"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD-087351"],"award-info":[{"award-number":["HD-087351"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation Leducq Transatlantic Networks of Excellence in Cardiovascular Research Robert A. Welch Foundation"},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["907611"],"award-info":[{"award-number":["907611"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41591-022-02176-5","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T12:03:14Z","timestamp":1676548994000},"page":"401-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":187,"title":["Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8651-0164","authenticated-orcid":false,"given":"Andreas C.","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3877-527X","authenticated-orcid":false,"given":"Francesco","family":"Chemello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-8349","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Atmanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"McAnally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3384-8887","authenticated-orcid":false,"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-4457","authenticated-orcid":false,"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-410X","authenticated-orcid":false,"given":"Rhonda","family":"Bassel-Duby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-8262","authenticated-orcid":false,"given":"Eric N.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"2176_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron, B. J. Clinical course and management of hypertrophic cardiomyopathy. N. Engl. J. Med 379, 655\u2013668 (2018).","journal-title":"N. Engl. J. Med"},{"key":"2176_CR2","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian, C., Ingles, J., Maron, M. S. & Maron, B. J. New perspectives on the prevalence of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 65, 1249\u20131254 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2176_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12551-017-0274-6","volume":"10","author":"DV Trivedi","year":"2018","unstructured":"Trivedi, D. V., Adhikari, A. S., Sarkar, S. S., Ruppel, K. M. & Spudich, J. A. Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light. Biophys. Rev. 10, 27\u201348 (2018).","journal-title":"Biophys. Rev."},{"key":"2176_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","volume":"62","author":"AA Geisterfer-Lowrance","year":"1990","unstructured":"Geisterfer-Lowrance, A. A. et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62, 999\u20131006 (1990).","journal-title":"Cell"},{"key":"2176_CR5","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.RES.86.7.737","volume":"86","author":"MJ Tyska","year":"2000","unstructured":"Tyska, M. J. et al. Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy. Circ. Res. 86, 737\u2013744 (2000).","journal-title":"Circ. Res."},{"key":"2176_CR6","doi-asserted-by":"publisher","first-page":"eaax0069","DOI":"10.1126\/sciadv.aax0069","volume":"6","author":"SS Sarkar","year":"2020","unstructured":"Sarkar, S. S. et al. The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin. Sci. Adv. 6, eaax0069 (2020).","journal-title":"Sci. Adv."},{"key":"2176_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"2176_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"2176_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","volume":"589","author":"LW Koblan","year":"2021","unstructured":"Koblan, L. W. et al. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice. Nature 589, 608\u2013614 (2021).","journal-title":"Nature"},{"key":"2176_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41551-020-00632-6","volume":"5","author":"S Suh","year":"2021","unstructured":"Suh, S. et al. Restoration of visual function in adult mice with an inherited retinal disease via adenine base editing. Nat. Biomed. Eng. 5, 169\u2013178 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"2176_CR11","doi-asserted-by":"publisher","first-page":"eabg4910","DOI":"10.1126\/sciadv.abg4910","volume":"7","author":"F Chemello","year":"2021","unstructured":"Chemello, F. et al. Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Sci. Adv. 7, eabg4910 (2021).","journal-title":"Sci. Adv."},{"key":"2176_CR12","unstructured":"Reichart, D. et al. Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice. Nat. Med. (2022)."},{"key":"2176_CR13","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2176_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891 (2020).","journal-title":"Nat. Biotechnol."},{"key":"2176_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"2176_CR16","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu, H. et al. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361, 1259\u20131262 (2018).","journal-title":"Science"},{"key":"2176_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490\u2013495 (2016).","journal-title":"Nature"},{"key":"2176_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian, A. J. & Braunwald, E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ. Res 121, 749\u2013770 (2017).","journal-title":"Circ. Res"},{"key":"2176_CR19","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic. Acid. Res. 46, W242\u2013W245 (2018).","journal-title":"Nucleic. Acid. Res."},{"key":"2176_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/CIRCGEN.119.002823","volume":"13","author":"CJ Pua","year":"2020","unstructured":"Pua, C. J. et al. Genetic studies of hypertrophic cardiomyopathy in Singaporeans identify variants in TNNI3 and TNNT2 that are common in Chinese patients. Circ. Genom. Precis. Med. 13, 424\u2013434 (2020).","journal-title":"Circ. Genom. Precis. Med."},{"key":"2176_CR21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","volume":"141","author":"CN Toepfer","year":"2020","unstructured":"Toepfer, C. N. et al. Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy. Circulation 141, 828\u2013842 (2020).","journal-title":"Circulation"},{"key":"2176_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.stemcr.2018.11.015","volume":"12","author":"R Cohn","year":"2019","unstructured":"Cohn, R. et al. A contraction stress model of hypertrophic cardiomyopathy due to sarcomere mutations. Stem Cell Rep. 12, 71\u201383 (2019).","journal-title":"Stem Cell Rep."},{"key":"2176_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fphys.2014.00309","volume":"5","author":"S Vakrou","year":"2014","unstructured":"Vakrou, S. & Abraham, M. R. Hypertrophic cardiomyopathy: a heart in need of an energy bar? Front. Physiol. 5, 309 (2014).","journal-title":"Front. Physiol."},{"key":"2176_CR24","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1083\/jcb.111.6.2427","volume":"111","author":"GE Lyons","year":"1990","unstructured":"Lyons, G. E., Schiaffino, S., Sassoon, D., Barton, P. & Buckingham, M. Developmental regulation of myosin gene expression in mouse cardiac muscle. J. Cell Biol. 111, 2427\u20132436 (1990).","journal-title":"J. Cell Biol."},{"key":"2176_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.272.5262.731","volume":"272","author":"AA Geisterfer-Lowrance","year":"1996","unstructured":"Geisterfer-Lowrance, A. A. et al. A mouse model of familial hypertrophic cardiomyopathy. Science 272, 731\u2013734 (1996).","journal-title":"Science"},{"key":"2176_CR26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/CIRCRESAHA.120.318674","volume":"129","author":"S Ma","year":"2021","unstructured":"Ma, S. et al. Efficient correction of a hypertrophic cardiomyopathy mutation by ABEmax-NG. Circ. Res. 129, 895\u2013908 (2021).","journal-title":"Circ. Res."},{"key":"2176_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCRESAHA.118.311587","volume":"123","author":"K Ishikawa","year":"2018","unstructured":"Ishikawa, K., Weber, T. & Hajjar, R. J. Human cardiac gene therapy. Circ. Res. 123, 601\u2013613 (2018).","journal-title":"Circ. Res."},{"key":"2176_CR28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.febslet.2009.02.003","volume":"583","author":"J Zettler","year":"2009","unstructured":"Zettler, J., Schutz, V. & Mootz, H. D. The naturally split Npu DnaE intein exhibits an extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett. 583, 909\u2013914 (2009).","journal-title":"FEBS Lett."},{"key":"2176_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"KM Prasad","year":"2011","unstructured":"Prasad, K. M., Xu, Y., Yang, Z., Acton, S. T. & French, B. A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 18, 43\u201352 (2011).","journal-title":"Gene Ther."},{"key":"2176_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"29","author":"JR Mendell","year":"2021","unstructured":"Mendell, J.R. et al. Current Clinical Applications of In Vivo Gene Therapy with AAVs. Mol. Ther. 29, 464\u2013488 (2021).","journal-title":"Mol. Ther."},{"key":"2176_CR31","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1172\/JCI42028","volume":"120","author":"P Teekakirikul","year":"2010","unstructured":"Teekakirikul, P. et al. Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-beta. J. Clin. Invest. 120, 3520\u20133529 (2010).","journal-title":"J. Clin. Invest."},{"key":"2176_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","volume":"118","author":"AR Pinto","year":"2016","unstructured":"Pinto, A. R. et al. Revisiting cardiac cellular composition. Circ. Res. 118, 400\u2013409 (2016).","journal-title":"Circ. Res."},{"key":"2176_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1126\/science.1236921","volume":"342","author":"J Jiang","year":"2013","unstructured":"Jiang, J., Wakimoto, H., Seidman, J. G. & Seidman, C. E. Allele-specific silencing of mutant Myh6 transcripts in mice suppresses hypertrophic cardiomyopathy. Science 342, 111\u2013114 (2013).","journal-title":"Science"},{"key":"2176_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0002-9343(61)90222-4","volume":"31","author":"JA Pare","year":"1961","unstructured":"Pare, J. A., Fraser, R. G., Pirozynski, W. J., Shanks, J. A. & Stubington, D. Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy. Am. J. Med. 31, 37\u201362 (1961).","journal-title":"Am. J. Med."},{"key":"2176_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1161\/01.CIR.89.1.22","volume":"89","author":"L Fananapazir","year":"1994","unstructured":"Fananapazir, L. & Epstein, N. D. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 89, 22\u201332 (1994).","journal-title":"Circulation"},{"key":"2176_CR36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","volume":"138","author":"CY Ho","year":"2018","unstructured":"Ho, C. Y. et al. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation 138, 1387\u20131398 (2018).","journal-title":"Circulation"},{"key":"2176_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1073\/pnas.1523918113","volume":"113","author":"KJ Carroll","year":"2016","unstructured":"Carroll, K. J. et al. A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9. Proc. Natl Acad. Sci. USA 113, 338\u2013343 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2176_CR38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.amjcard.2010.10.022","volume":"107","author":"BJ Maron","year":"2011","unstructured":"Maron, B. J., Yeates, L. & Semsarian, C. Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy. Am. J. Cardiol. 107, 604\u2013608 (2011).","journal-title":"Am. J. Cardiol."},{"key":"2176_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1126\/science.aad3456","volume":"351","author":"EM Green","year":"2016","unstructured":"Green, E. M. et al. A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. Science 351, 617\u2013621 (2016).","journal-title":"Science"},{"key":"2176_CR40","doi-asserted-by":"publisher","first-page":"e0168407","DOI":"10.1371\/journal.pone.0168407","volume":"11","author":"JA Stern","year":"2016","unstructured":"Stern, J. A. et al. A small molecule inhibitor of sarcomere contractility acutely relieves left ventricular outflow tract obstruction in feline hypertrophic cardiomyopathy. PLoS ONE 11, e0168407 (2016).","journal-title":"PLoS ONE"},{"key":"2176_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/gt.2012.14","volume":"19","author":"D Ladage","year":"2012","unstructured":"Ladage, D., Ishikawa, K., Tilemann, L., Muller-Ehmsen, J. & Kawase, Y. Percutaneous methods of vector delivery in preclinical models. Gene Ther. 19, 637\u2013641 (2012).","journal-title":"Gene Ther."},{"key":"2176_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"2176_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265 e216 (2022).","journal-title":"Cell"},{"key":"2176_CR44","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","volume":"184","author":"M Tabebordbar","year":"2021","unstructured":"Tabebordbar, M. et al. Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Cell 184, 4919\u20134938 e4922 (2021).","journal-title":"Cell"},{"key":"2176_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19230-w","volume":"11","author":"J Weinmann","year":"2020","unstructured":"Weinmann, J. et al. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat. Commun. 11, 5432 (2020).","journal-title":"Nat. Commun."},{"key":"2176_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/0012-1606(81)90396-1","volume":"84","author":"AM Lompre","year":"1981","unstructured":"Lompre, A. M. et al. Species- and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev. Biol. 84, 286\u2013290 (1981).","journal-title":"Dev. Biol."},{"key":"2176_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ahj.2021.05.007","volume":"239","author":"MY Desai","year":"2021","unstructured":"Desai, M. Y. et al. Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy. Am. Heart J. 239, 80\u201389 (2021).","journal-title":"Am. Heart J."},{"key":"2176_CR48","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","volume":"143","author":"S Saberi","year":"2021","unstructured":"Saberi, S. et al. Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM Cardiac Magnetic Resonance Substudy Analysis. Circulation 143, 606\u2013608 (2021).","journal-title":"Circulation"},{"key":"2176_CR49","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s40265-022-01739-7","volume":"82","author":"SJ Keam","year":"2022","unstructured":"Keam, S.J. Mavacamten: First Approval. Drugs 82, 1127\u20131135 (2022).","journal-title":"Drugs"},{"key":"2176_CR50","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","volume":"75","author":"CY Ho","year":"2020","unstructured":"Ho, C. Y. et al. Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 75, 2649\u20132660 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2176_CR51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cardiores.2007.03.025","volume":"75","author":"E Murphy","year":"2007","unstructured":"Murphy, E. & Steenbergen, C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 75, 478\u2013486 (2007).","journal-title":"Cardiovasc. Res."},{"key":"2176_CR52","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"2176_CR53","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41587-019-0134-y","volume":"37","author":"TP Huang","year":"2019","unstructured":"Huang, T. P. et al. Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors. Nat. Biotechnol. 37, 626\u2013631 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2176_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"2176_CR55","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nmeth.2999","volume":"11","author":"PW Burridge","year":"2014","unstructured":"Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat. Method. 11, 855\u2013860 (2014).","journal-title":"Nat. Method."},{"key":"2176_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08713-4","volume":"7","author":"C Correia","year":"2017","unstructured":"Correia, C. et al. Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci. Rep. 7, 8590 (2017).","journal-title":"Sci. Rep."},{"key":"2176_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"2176_CR58","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/CIRCRESAHA.121.319579","volume":"129","author":"A Atmanli","year":"2021","unstructured":"Atmanli, A. et al. Cardiac myoediting attenuates cardiac abnormalities in human and mouse models of Duchenne muscular dystrophy. Circ. Res. 129, 602\u2013616 (2021).","journal-title":"Circ. Res."},{"key":"2176_CR59","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.stemcr.2015.10.017","volume":"5","author":"JD Kijlstra","year":"2015","unstructured":"Kijlstra, J. D. et al. Integrated analysis of contractile kinetics, force generation, and electrical activity in single human stem cell-derived cardiomyocytes. Stem Cell Rep. 5, 1226\u20131238 (2015).","journal-title":"Stem Cell Rep."},{"key":"2176_CR60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"2176_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2176_CR62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nprot.2017.153","volume":"13","author":"H Miura","year":"2018","unstructured":"Miura, H., Quadros, R. M., Gurumurthy, C. B. & Ohtsuka, M. Easi-CRISPR for creating knock-in and conditional knockout mouse models using long ssDNA donors. Nat. Protoc. 13, 195\u2013215 (2018).","journal-title":"Nat. Protoc."},{"key":"2176_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-0716-1480-8_2","volume":"2319","author":"HA Creed","year":"2021","unstructured":"Creed, H. A. & Tong, C. W. Preparation and identification of cardiac myofibrils from whole heart samples. Methods Mol. Biol. 2319, 15\u201324 (2021).","journal-title":"Methods Mol. Biol."},{"key":"2176_CR64","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.xpro.2020.100049","volume":"1","author":"M Cui","year":"2020","unstructured":"Cui, M. & Olson, E. N. Protocol for single-nucleus transcriptomics of diploid and tetraploid cardiomyocytes in murine hearts. STAR Protoc. 1, 100049 (2020).","journal-title":"STAR Protoc."},{"key":"2176_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02176-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02176-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02176-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T14:05:48Z","timestamp":1677765948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-022-02176-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1038\/s41591-022-02176-5","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"28 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.N.O. is a consultant for Vertex Pharmaceuticals and Tenaya Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}